what happens when you stop taking l-carnitine Role of in Cardiovascular Health: Literature Review When to take L-carnitine –

Structural studies have revealed that this strong preference is due to geometrical and conformational constraints that occur between a cofactor and a cofactor binding site on the LBD (PDB: 1T7R) 82,84

However, this issue requires more clinical studies to determine the appropriate dose and confirm its effectiveness in treating this disease

Further research on these supplements and the MS should be continued with new and bigger clinical trials

The observed prevalence of deficiency (66% of screened patients) aligns with prior reports in pediatric HD populations, reflecting both dialysis-related losses and reduced endogenous synthesis [4, 7]